NYSE:DBDDiebold Nixdorf Stock Price, Forecast & News

Diebold Nixdorf's stock was trading at $5.21 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, DBD shares have increased by 63.5% and is now trading at $8.52.
View which stocks have been most impacted by COVID-19.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Diebold Nixdorf in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Diebold Nixdorf.

Diebold Nixdorf is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Diebold Nixdorf.

Diebold Nixdorf Inc (NYSE:DBD) issued its earnings results on Thursday, July, 30th. The technology company reported $0.38 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.01 by $0.37. The technology company had revenue of $890.50 million for the quarter, compared to analyst estimates of $848.84 million. Diebold Nixdorf had a negative net margin of 6.82% and a negative return on equity of 5.88%.
View Diebold Nixdorf's earnings history.

Diebold Nixdorf updated its FY 2020 Pre-Market earnings guidance on Thursday, July, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $3.7-3.9 billion, compared to the consensus revenue estimate of $3.79 billion.

4 brokers have issued 12 month target prices for Diebold Nixdorf's shares. Their forecasts range from $7.00 to $19.00. On average, they expect Diebold Nixdorf's share price to reach $14.33 in the next twelve months. This suggests a possible upside of 68.2% from the stock's current price.
View analysts' price targets for Diebold Nixdorf.

News headlines about DBD stock have trended extremely negative recently, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Diebold Nixdorf earned a media sentiment score of -4.1 on InfoTrie's scale. They also assigned news stories about the technology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future.
View the latest news about Diebold Nixdorf.

Diebold Nixdorf saw a decrease in short interest in July. As of July 31st, there was short interest totaling 11,140,000 shares, a decrease of 11.4% from the July 15th total of 12,580,000 shares. Based on an average daily trading volume, of 1,490,000 shares, the days-to-cover ratio is presently 7.5 days. Approximately 14.8% of the company's stock are short sold.
View Diebold Nixdorf's Short Interest.

Some companies that are related to Diebold Nixdorf include Apple (AAPL), Dell (DELL), HP (HPQ), NCR (NCR), Super Micro Computer (SMCI), Stratasys (SSYS), 3D Systems (DDD), Avid Technology (AVID) and Kopin (KOPN).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Diebold Nixdorf investors own include AbbVie (ABBV), Chicago Bridge & Iron (CBI), Bristol-Myers Squibb (BMY), KKR & Co Inc (KKR), Philip Morris International (PM), Vector Group (VGR), Johnson Controls International (JCI), Mattel (MAT), Mondelez International (MDLZ) and Dunkin Brands Group (DNKN).

Diebold Nixdorf trades on the New York Stock Exchange (NYSE) under the ticker symbol "DBD."

Diebold Nixdorf's stock is owned by a number of institutional and retail investors. Top institutional investors include Victory Capital Management Inc. (3.10%), Smith Graham & Co. Investment Advisors LP (2.24%), Bank of New York Mellon Corp (1.19%), Prudential Financial Inc. (1.11%), Principal Financial Group Inc. (0.87%) and Goldman Sachs Group Inc. (0.79%). Company insiders that own Diebold Nixdorf stock include Arthur F Anton, Bruce H Besanko, Ellen Costello, Gary G Greenfield, Gerrard Schmid, Jeffrey L Rutherford, Lauren States, Matthew Goldfarb, Olaf Robert Heyden, Phillip R Cox and Ulrich Naher.
View institutional ownership trends for Diebold Nixdorf.

DBD stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., UBS Group AG, Victory Capital Management Inc., Bank of New York Mellon Corp, California Public Employees Retirement System, State of Wisconsin Investment Board, Kovack Advisors Inc., and Texas Permanent School Fund.
View insider buying and selling activity for Diebold Nixdorf.

DBD stock was purchased by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP, Russell Investments Group Ltd., New York State Common Retirement Fund, Principal Financial Group Inc., Leap Investments LP, MERIAN GLOBAL INVESTORS UK Ltd, Bank of Montreal Can, and Goldman Sachs Group Inc.. Company insiders that have bought Diebold Nixdorf stock in the last two years include Arthur F Anton, Bruce H Besanko, Ellen Costello, Gary G Greenfield, Gerrard Schmid, Jeffrey L Rutherford, Lauren States, Matthew Goldfarb, Olaf Robert Heyden, and Ulrich Naher.
View insider buying and selling activity for Diebold Nixdorf.

Shares of DBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of DBD stock can currently be purchased for approximately $8.52.

Diebold Nixdorf has a market capitalization of $661.79 million and generates $4.41 billion in revenue each year. The technology company earns $-341,300,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Diebold Nixdorf employs 22,000 workers across the globe.

The official website for Diebold Nixdorf is www.dieboldnixdorf.com.

Diebold Nixdorf's mailing address is 5995 MAYFAIR RD P.O. BOX 3077, NORTH CANTON OH, 44720. The technology company can be reached via phone at 330-490-4000 or via email at [email protected]